Off With Their Heads
This article was originally published in Start Up
Executive Summary
A number of recent management shake-ups, in the midst of biotech's deep depression, are an indication of the industry's desperation to find a solution to its stock market woes--as well as the exhaustion of leaders tired of trying to break through Wall Street's attention barriers.